04/17/2024
5:01 PM | GILL SIMBA (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:57 PM | GILL SIMBA (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2024
3:22 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:18 PM | Bailey Gregory (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:59 PM | MINTZ STEVEN (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:55 PM | Gross Remy (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:56 PM | HARRIS J MILTON (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/03/2024
7:58 PM | Marshall Richard Peter (Reporting)
AgeX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:26 PM | Moreadith Randall (Filed by)
AgeX Therapeutics (Subject)
| Form SC 13D | |
04/03/2024
7:02 PM | LEDGER STEVEN A (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
7:05 PM | Marshall Richard Peter (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
7:07 PM | Moreadith Randall (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
7:08 PM | AgeX Therapeutics (Issuer)
Viegas Tacey (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:55 PM | Gross Remy (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:59 PM | HARRIS J MILTON (Reporting)
AgeX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
4:27 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
4:27 PM | AgeX Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
4:28 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:47 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:49 PM | AgeX Therapeutics (Subject)
| Form 425 | |
03/07/2024
6:47 AM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
02/06/2024
9:00 PM | AgeX Therapeutics (Filer)
| Form S-4/A | |
02/05/2024
6:19 AM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
01/19/2024
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:29 PM | AgeX Therapeutics (Issuer)
MINTZ STEVEN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
3:19 PM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
01/16/2024
8:11 AM | AgeX Therapeutics (Filer)
| Form S-4/A | |
01/11/2024
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:16 PM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
12/18/2023
3:25 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
4:11 PM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
12/01/2023
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
8:38 AM | AgeX Therapeutics (Filer)
| Form DEF 14A | |
11/14/2023
3:25 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:16 PM | AgeX Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:28 PM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
10/06/2023
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:05 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
6:20 AM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
3:48 PM | AgeX Therapeutics (Subject)
Juvenescence Ltd (Filed by)
| Form SC 13D/A | |
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad) The FEDNOW Biden Dollar ends cash in a matter of WEEKS
Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next.
In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW |
08/21/2023
3:40 PM | AgeX Therapeutics (Issuer)
Renondin Jean-Christophe (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/21/2023
4:29 PM | AgeX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
3:16 PM | AgeX Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
